Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2010
11/25/2010US20100298347 Substituted 2-naphthoic acids as antagonists of gpr105 activity
11/25/2010US20100298339 [1,2,4]Triazolo[1,5-a]Pyridine and [1,2,4]Triazolo[1,5-c]Pyrimidine Compounds and Their Use
11/25/2010US20100298334 N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
11/25/2010US20100298331 Triazinone and diazinone derivatives useful as hsp90 inhibitors
11/25/2010US20100298315 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmnaceutical compositions and novel use as met inhibitors
11/25/2010US20100298302 Novel protein kinase modulators
11/25/2010US20100298300 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases
11/25/2010US20100298292 Modulators of 5-ht receptors and methods of use thereof
11/25/2010US20100298289 Heterobicyclic compounds as histamine h4-receptor antagonists
11/25/2010US20100298287 Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
11/25/2010US20100297762 Photodynamic therapy using chemiluminescence and a ligand-photosensitiser conjugate
11/25/2010US20100297556 Coating compositions suitable for use with an overcoated photoresist
11/25/2010US20100297128 Gamma secretase modulators
11/25/2010US20100297035 Thiazole Amides, Imidazole Amides and Related Analogues
11/25/2010US20100297009 Self-assembled polyhedral multimeric chemical structures
11/25/2010CA2763099A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
11/25/2010CA2762313A1 Pyrazolopyrimidines and related heterocycles as kinase inhibitors
11/25/2010CA2762174A1 N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
11/25/2010CA2761961A1 Modulators of 5-ht receptors and methods of use thereof
11/25/2010CA2761954A1 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
11/24/2010EP2253673A1 Azo compound, azo pigment, and dispersion, colored composition, ink-jet recording ink, ink-jet recording ink tank, ink-jet recording method and recorded material each containing the azo compound or the azo pigment
11/24/2010EP2253672A1 Azo compound, azo pigment, and dispersion, colored composition, ink-jet recording ink, ink-jet recording ink tank, ink-jet recording method and recorded material each containing the azo compound or the azo pigment
11/24/2010EP2253634A1 Liquid porphyrin derivative and method for producing the same
11/24/2010EP2253633A1 Fused heterocyclic compound
11/24/2010EP2253632A1 Pyrazolopyramidinone derivatives, their preparation and their use
11/24/2010EP2253614A1 Inhibitors of IAP
11/24/2010EP2253328A1 Cycloalkyl inhibitors of potassium channel function
11/24/2010EP2252618A1 PYRAZOLO [1,5-a] PYRIMIDINES USEFUL AS JAK2 INHIBITORS
11/24/2010EP2252617A1 6-aryl-imidaz0[l, 2-a]pyrazine derivatives, method of making, and method of use thereof
11/24/2010EP2252616A1 Pyrazolopyrimidine pi3k inhibitor compounds and methods of use
11/24/2010EP2252615A1 Dihydro- 1h- pyrrolo [1,2-a]indol-1-yl carboxylic derivatives which act as s1p1 agonists
11/24/2010EP2252596A1 Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
11/24/2010EP2252595A1 Oxim derivatives as hsp90 inhibitors
11/24/2010EP2252296A1 3h-[1,2,3]triazolo[4,5-d]pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
11/24/2010EP2152711B1 2 -heteroaryl- pyrrolo [3, 4-c]pyrrole derivatives and their use as scd inhibitors
11/24/2010EP1999122B1 Stationary phase and column using cucurbituril bonded silica gel, and separation method of taxol using the column
11/24/2010EP1899330B1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
11/24/2010EP1603917B1 Immunomodulating heterocyclic compounds
11/24/2010EP1497287B1 Quinoline derivatives in combination with 5-FU or CPT-11 for use in the treatment of cancer
11/24/2010CN101896486A Spiroindolinone derivatives
11/24/2010CN101896485A Novel compounds of reverse turn mimetics and the use thereof (3)
11/24/2010CN101896459A Anthelmintic agents and their use
11/24/2010CN101891748A Synthesis method of branched chain intermediate of biapenem
11/24/2010CN101891747A Compound capable of inhibiting phosphodiesterase type 5 and preparation method
11/24/2010CN101160311B Polymorphic form of 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-lh-pyrrolizin-5-ylacetic acid
11/23/2010US7838674 2-(1-amino-cyclobutylmethyl)-8-(4-methoxy-phenyl)-4,5-dihydro-1 H-1,7,9-triazacyclopenta[a]naph-thalene-3-carboxylic acid lactame; useful especially as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 (MK2 or MAPKAP kinase-2
11/23/2010US7838672 7-Methoxy-1-methyl[1,2,4]triazolo[3,4-c][1,2,4]benzotriazine; pre-emergence and post-emergence herbicides
11/23/2010US7838670 Naphthalocyanine compound and method for producing the same
11/23/2010US7838669 useful for image-forming materials, IR-sensitive thermal recording materials, optical recording devices and optical film materials
11/23/2010US7838547 obesity and diabetes; Melanin Concentrating Hormone inhibitors; antagonism of MCH1R;
11/23/2010US7838528 Substituted bicyclic 8-pyrrolidinoxanthines, methods for their production, pharmaceutical formulations and their use
11/23/2010US7838520 Inhibitors of histone deacetylase
11/23/2010US7838518 1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic acid [2-(1-methyl-pyrrolidin-2-yl)-ethyl]amide; selective affinity for 5-HT6 receptor; psychosis, schizophrenia, depression, neurological disorders, cognitive enhancement, Parkinson's disease, ALS, Alzheimer's, Huntington's disease
11/23/2010CA2503223C Meso-substituted porphyrins
11/18/2010WO2010132598A1 Heteroaryl compounds as pikk inhibitors
11/18/2010WO2010132538A1 Fused tricyclic aryl compounds useful for the treatment of viral diseases
11/18/2010WO2010132110A1 Hydrochloride salt of ((1s,2s,4r)-4-{4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo [2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
11/18/2010WO2010132015A1 New compounds modulating gamma-secretase and their use in the treatment of alpha beta related pathologies, such as alzheimer's disease
11/18/2010WO2010131145A1 Cyclobutenedione derivatives
11/18/2010WO2010131035A1 Novel crystalline polymorph of sitagliptin dihydrogen phosphate
11/18/2010WO2010131025A1 Sitagliptin synthesis
11/18/2010WO2010131022A1 [1,2,4] triazolo [4,3-b] pyridazines as ligands of the androgen receptor
11/18/2010WO2010130768A1 Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulators
11/18/2010WO2010130065A1 A method for synthesizing tetraaryl porphyrin and its device
11/18/2010WO2010071846A3 Compounds for treating neuropsychiatric conditions
11/18/2010WO2010059611A3 Inhibitors of diacylglycerol acyltransferase
11/18/2010WO2010056644A8 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
11/18/2010WO2010034838A3 Antiproliferative compounds
11/18/2010WO2010000469A3 Crystalline salts of sitagliptin
11/18/2010WO2009134531A3 Total synthesis of salinosporamide a and analogs thereof
11/18/2010US20100292465 Catalysts containing n-heterocyclic carbenes for enantioselective synthesis
11/18/2010US20100292463 Process for production of b-lactam compound
11/18/2010US20100292289 Treatment of metabolic syndrome with novel amides
11/18/2010US20100292256 (EN) 2-ALKYLAMINO-3-ARYLSULFONYL-CYCLOALCANO [e OR d] PYRAZOLO [1,5-A]PYRIMIDINES / ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THE PRODUCTION AND THE USE THEREOF
11/18/2010US20100292245 (en) substituted 2-amino-3-sulfonyl-pyrazolo[1,5-a] pyrimidines/antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof
11/18/2010US20100292241 3,5-substituted-1,3-oxazolidin-2-one derivatives
11/18/2010US20100292238 Phenoxymethyl Heterocyclic Compounds
11/18/2010US20100292233 Dihydro-1h-pyrrolo[1,2-a]indol-1-yl carboxylic acid derivatives which act as s1p1 agonists
11/18/2010US20100292222 Chemical compounds 751
11/18/2010US20100292214 Compounds with Antiparasitic Activity, Applications thereof to the Treatment of Infectious Diseases Caused by Apicomplexans
11/18/2010US20100292205 Pyrimidone Compounds As GSK-3 Inhibitors
11/18/2010US20100291026 Piperidine inhibitors of janus kinase 3
11/18/2010US20100290992 Nanoparticle nucleic acid binding compound conjugates forming i-motifs
11/18/2010CA2761650A1 Macrocyclic compounds as hepatitis c virus inhibitors
11/18/2010CA2761256A1 Hydrochloride salt of ((1s,2s,4r)-4-{4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo [2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
11/18/2010CA2760778A1 Heteroaryl compounds as pikk inhibitors
11/18/2010CA2760205A1 Fused tricyclic aryl compounds useful for the treatment of viral diseases
11/18/2010CA2759884A1 [1,2,4] triazolo [4,3-b] pyridazines as ligands of the androgen receptor
11/18/2010CA2759196A1 Novel crystalline polymorph of sitagliptin dihydrogen phosphate
11/18/2010CA2759077A1 Sitagliptin synthesis
11/17/2010EP2251327A2 Heterocyclic inhibitors of MEK and methods of use thereof
11/17/2010EP2250178A2 Improved process for preparation of triazol-benzodiazepine derivatives
11/17/2010EP2250174A2 Macrocyclic serine protease inhibitors
11/17/2010EP2250173A1 Imidazopyrazinol derivatives for the treatment of cancers
11/17/2010EP2250172A1 Pyrrolopyrazine kinase inhibitors
11/17/2010EP2250167A1 Arylmethylidene heterocycles as novel analgesics
11/17/2010EP2250157A1 Novel heterocyclic compounds
11/17/2010EP2250155A1 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors
11/17/2010EP2249649A2 An improved process for preparation of paliperidone
11/17/2010EP2170260B1 Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres
1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 573